NicOx Expects To File NDA For Osteoarthritis Drug In 2009
This article was originally published in The Pink Sheet Daily
Executive Summary
The French company says it would need a partner to launch the drug, a potential competitor to Pfizer’s Celebrex.
You may also be interested in...
NicOx Osteoarthritis NDA Filing On Track Following FDA Correspondence
FDA says a clinical cardiovascular outcomes trial is not required.
NicOx Osteoarthritis NDA Filing On Track Following FDA Correspondence
FDA says a clinical cardiovascular outcomes trial is not required.